CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration
- PMID: 17420923
- DOI: 10.1007/s00415-006-0481-8
CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration
Abstract
Background and methods: The light subunit of the neurofilament protein (NFL), a major structural component of myelinated axons, is a sensitive indicator of axonal injury in the central nervous system (CNS) in a variety of neurodegenerative disorders. Cerebrospinal fluid (CSF) NFL concentrations were measured by ELISA (normal < 250 ng/l) in archived samples from 210 HIV-infected patients not taking antiretroviral treatment: 55 with AIDS dementia complex (ADC), 44 with various CNS opportunistic infections/tumours (CNS OIs), 95 without neurological symptoms or signs, and 16 with primary HIV infection (PHI). The effect of highly active antiretroviral treatment (HAART) was studied by repeated CSF sampling in four of the ADC patients initiating treatment.
Results: CSF NFL concentrations were significantly higher in patients with ADC (median 2590 ng/l, IQR 780-7360) and CNS OIs (2315 ng/l, 985-7390 ng/l) than in neuroasymptomatic patients (<250 ng/l, <250-300) or PHI (<250 ng/l, <250-280), p < 0.001. Among patients with ADC, those with more severe disease (stage 2-4) had higher levels than those with milder disease (stage 0.5-1), p < 0.01. CSF NFL declined during HAART to the limit of detection in parallel with virological response and neurological improvement in ADC.CSF NFL concentrations were higher in neuroasymptomatic patients with lower CD4-cell strata than higher, p < 0.001. This increase was less marked than in the ADC patients and noted in 26/58 neuroasymptomatic patients with CD4 counts <200/microl compared to 1/37 with CD4-cells > or =200/microl.
Conclusions: The findings of this study support the value of CSF NFL as a useful marker of ongoing CNS damage in HIV infection. Markedly elevated CSF NFL concentrations in patients without CNS OIs are associated with ADC, follow the grade of severity, and decrease after initiation of effective antiretroviral treatment. Nearly all previously suggested CSF markers of ADC relate to immune activation or HIV viral load that do not directly indicate brain injury. By contrast NFL is a sensitive marker of such injury, and should prove useful in evaluating the presence and activity of ongoing CNS injury in HIV infection.
Similar articles
-
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.Neurology. 2007 Oct 9;69(15):1536-41. doi: 10.1212/01.wnl.0000277635.05973.55. Neurology. 2007. PMID: 17923616
-
Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.PLoS One. 2014 Feb 11;9(2):e88591. doi: 10.1371/journal.pone.0088591. eCollection 2014. PLoS One. 2014. PMID: 24523921 Free PMC article.
-
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.EBioMedicine. 2015 Nov 22;3:135-140. doi: 10.1016/j.ebiom.2015.11.036. eCollection 2016 Jan. EBioMedicine. 2015. PMID: 26870824 Free PMC article.
-
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.Expert Rev Mol Diagn. 2017 Aug;17(8):761-770. doi: 10.1080/14737159.2017.1341313. Epub 2017 Jun 14. Expert Rev Mol Diagn. 2017. PMID: 28598205 Review.
-
Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.J Neuroimmune Pharmacol. 2007 Mar;2(1):112-9. doi: 10.1007/s11481-006-9035-1. Epub 2006 Sep 12. J Neuroimmune Pharmacol. 2007. PMID: 18040834 Review.
Cited by
-
Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.PLoS One. 2014 Dec 26;9(12):e116081. doi: 10.1371/journal.pone.0116081. eCollection 2014. PLoS One. 2014. PMID: 25541953 Free PMC article.
-
Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection.PLoS One. 2016 Jul 21;11(7):e0158973. doi: 10.1371/journal.pone.0158973. eCollection 2016. PLoS One. 2016. PMID: 27441551 Free PMC article.
-
Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.J Infect Dis. 2013 Jun 1;207(11):1703-12. doi: 10.1093/infdis/jit088. Epub 2013 Mar 4. J Infect Dis. 2013. PMID: 23460748 Free PMC article.
-
Diagnostic and prognostic biomarkers for HAND.J Neurovirol. 2019 Oct;25(5):686-701. doi: 10.1007/s13365-018-0705-6. Epub 2019 Jan 3. J Neurovirol. 2019. PMID: 30607890 Free PMC article. Review.
-
Antiretroviral therapy and central nervous system HIV type 1 infection.J Infect Dis. 2008 May 15;197 Suppl 3(Suppl 3):S294-306. doi: 10.1086/533419. J Infect Dis. 2008. PMID: 18447615 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous